| Title |
Date |
| Inflammatory bowel disorders can raise risk of osteoporotic fractures |
05/07/10 |
| A team of scientists from the University Hospitals of Geneva and Lausanne have shown that young people with inflammatory bowel diseases have low bone mass and poor bone architecture compared to healthy people of the same age, placing them at increased risk of fracture. |
| NSF CAREER award for nanotechnology cancer treatment |
05/07/10 |
| The use of rapid point-of-care diagnostic tests for the measurement of CD4 T-cells, a marker of the immune system will be an important factor in improving the lives of people living with HIV and AIDS especially in developing and resource-poor countries. |
| Obama signs bill to expand health care access for veterans, provide more caregiver benefits |
05/07/10 |
| This article is republished with kind permission from our friends at The Kaiser Family Foundation. |
| Resolvyx presents new data on RX-10001 for corneal herpes simplex virus infection at ARVO 2010 |
05/07/10 |
| Resolvyx Pharmaceuticals, Inc., the leading resolving therapeutics company, today announced the presentation of data on its novel resolvins for the treatment of both ocular surface diseases and retinal diseases at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale, Florida, being held May 2-6, 2010. |
| ONGLYZA-metformin combination: FDA accepts NDA for review |
03/30/10 |
| Bristol-Myers Squibb Company and AstraZeneca today announced that the FDA has accepted for review a New Drug Application for an investigational fixed dose combination of ONGLYZA (saxagliptin), a dipeptidyl peptidase-4 (DPP4) inhibitor, and metformin HCl extended-release tablets as a once-daily treatment for type 2 diabetes mellitus in adults. |
| Cumberland Pharmaceuticals submits Acetadote sNDA for non-acetaminophen acute liver failure |
03/30/10 |
| Cumberland Pharmaceuticals Inc has submitted a supplemental new drug application (sNDA) to the FDA for the use of Acetadote® (acetylcysteine) Injection in patients with non-acetaminophen acute liver failure. |
| First Edition: March 30, 2010 |
03/30/10 |
| Today's news pages are full of stories detailing more particulars of the new health care bill to be signed into law today by President Obama. |
| Healthy hearts: Interventions needed to keep people exercising following cardiac rehabilitation programs |
03/30/10 |
| Researchers from the Frances Payne Bolton School of Nursing at Case Western Reserve University found that one year after 248 individuals completed a 12-week cardiac rehabilitation program following a heart attack, bypass surgery or angioplasty, only 37% exercised three times a week to keep their hearts healthy. |
| Kun Run Biotechnology's fiscal 2009 fourth-quarter revenues down 19% |
03/30/10 |
| Kun Run Biotechnology Inc a leading bio-pharmaceutical company in China that focuses on manufacturing and sales of
peptides and peptide-based drugs, today announced its financial results for the fourth quarter and fiscal year ended December 31, 2009. |
| MedBuild receives MBI's 2010 Awards of Distinction for Nash Memorial Hospital Project |
03/30/10 |
| Modular Building Institute (MBI) has named MedBuild, a healthcare division of ModSpace, first-place winner for their 2010 Awards of Distinction. |
| National Donate Life Month: Facts surrounding dire need for organ donations |
03/30/10 |
| With April 1, 2010, marking the start of "National Donate Life Month," Health Net, Inc. is working to increase awareness regarding the urgent need for organ donations - particularly among minority populations - and also to dispute some of the misperceptions surrounding organ donation.
|
